| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | Chief Executive Officer | Jul 27, 2025 | Award/Grant | $8.30 | 6,068 | 50,379 | 13,312 | Jul 29, 2025, 04:15 PM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Nov 25, 2024 | Award/Grant | $1.17 | 42,553 | 50,000 | 202,859 | Nov 26, 2024, 04:12 PM | |
| TVTX | Travere Therapeutics, Inc. | Jeffrey A. Meckler | Director | Sep 30, 2024 | Option/RSU Exercise | $10.48 | 40,000 | 419,200 | 121,000 | Sep 30, 2024, 08:38 PM | |
| TVTX | Travere Therapeutics, Inc. | Jeffrey A. Meckler | Director | Sep 30, 2024 | Sale | $14.06 | 40,000 | 562,324 | 81,000 | Sep 30, 2024, 08:38 PM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Aug 08, 2024 | Award/Grant | $1.83 | 84,932 | 155,001 | 160,306 | Aug 08, 2024, 05:30 PM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Nov 18, 2022 | Buy | $1.76 | 400 | 705 | 65,774 | Nov 22, 2022, 08:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Nov 21, 2022 | Buy | $1.90 | 9,600 | 18,240 | 75,374 | Nov 22, 2022, 08:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Sep 08, 2022 | Buy | $2.80 | 10,308 | 28,862 | 65,374 | Sep 12, 2022, 09:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Sep 06, 2022 | Buy | $2.44 | 1,060 | 2,586 | 46,434 | Sep 08, 2022, 09:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Sep 07, 2022 | Buy | $2.57 | 8,632 | 22,184 | 55,066 | Sep 08, 2022, 09:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Jun 06, 2022 | Buy | $2.63 | 19,727 | 51,882 | 45,374 | Jun 07, 2022, 08:00 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Nov 18, 2021 | Buy | $5.82 | 11,187 | 65,108 | 25,647 | Nov 19, 2021, 09:16 AM | |
| INDP | Indaptus Therapeutics, Inc. | Jeffrey A. Meckler | CEO and Director | Sep 14, 2021 | Buy | $7.00 | 12,000 | 84,000 | 14,460 | Sep 16, 2021, 06:22 PM | |
| COCP | Cocrystal Pharma, Inc. | Jeffrey A. Meckler | CHIEF EXECUTIVE OFFICER | Mar 15, 2016 | Buy | $0.51 | 294,118 | 150,000 | 657,161 | Mar 17, 2016, 04:05 PM | |
| RTRX | Retrophin, Inc. | Jeffrey A. Meckler | Director | Mar 04, 2016 | Buy | $15.31 | 5,000 | 76,564 | 52,000 | Mar 07, 2016, 08:50 PM | |
| RTRX | Retrophin, Inc. | Jeffrey A. Meckler | Director | Mar 03, 2016 | Buy | $14.45 | 10,000 | 144,500 | 47,000 | Mar 03, 2016, 06:49 PM | |
| COCP | Cocrystal Pharma, Inc. | Jeffrey A. Meckler | CHIEF EXECUTIVE OFFICER | Dec 23, 2015 | Buy | $0.58 | 100,000 | 57,870 | 363,043 | Dec 28, 2015, 04:05 PM | |
| COCP | Cocrystal Pharma, Inc. | Jeffrey A. Meckler | Director | Mar 25, 2015 | Buy | $0.92 | 163,043 | 150,000 | 263,043 | Mar 27, 2015, 04:16 PM | |
| COCP | Cocrystal Pharma, Inc. | Jeffrey A. Meckler | Director | Dec 11, 2014 | Buy | $0.46 | 100,000 | 45,610 | 100,000 | Dec 15, 2014, 04:17 PM | |
| RTRX | Retrophin, Inc. | Jeffrey A. Meckler | Director | Nov 25, 2014 | Buy | $8.60 | 15,000 | 129,050 | 35,000 | Nov 25, 2014, 03:16 PM |